tirzepatide trial results of the phase 3b TOGETHER-PsA showed ixekizumab administered together with in comorbid overweight or obese adults with psoriatic arthritis showed clinically meaningful improvement of psoriatic disease, physical function, weight FDA Approves Tirzepatide, A Potential
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15


01200-X/asset/1ec2c191-5a64-4856-842f-bfa65a8fabc6/main.assets/gr2.jpg)























